⚡US FDA Approves Much-Debated Alzheimer's Drug Panned by Experts, First In Nearly 2 Decades
By PTI
The new medicine is made from living cells that will have to be given via infusion at a doctor's office or hospital. The most common side effects were inflammation in the brain, most cases did not cause symptoms or lasting problems.